Follikuláris limfóma: vizsgálatok itt: Egyesült Államok
103 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleAnti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 36
- Run by
- C. Babis Andreadis
See details and how to joinNCT04545762 - 2. fázisTaking peoplePhase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 83
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06108232 - 1/2. fázisTaking peopleGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Where
- Chapel Hill, Columbus, Denver, Duarte, Houston, Jacksonville, Los Angeles, Nashville, Portland, Rochester, Valhalla
- Életkor
- 13 év to 90 év
- People
- 32
- Run by
- Vironexis Biotherapeutics Inc.
See details and how to joinNCT06533579 - 3. fázisTaking peopleA Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 18 év and over
- People
- 375
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07029217 - 2. fázisTaking peopleObinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- Where
- Valhalla
- Életkor
- 3 év to 31 év
- People
- 25
- Run by
- New York Medical College
See details and how to joinNCT02393157 - 3. fázisTaking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Albany, Anchorage, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Baton Rouge, Bethesda, Blue Ash, Boston, Brooklyn, Charlotte, Chesterfield, Cincinnati, Clovis, Columbia, Columbus, Des Moines, Detroit, Eugene, Evanston, Fairfax, Fort Wayne, Hackensack, Huntsville, Iowa City, Jacksonville, Lexington, Los Alamitos, Louisville, Lubbock, Macon, Madison, Milwaukee, Mineola, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New York, Peoria, Phoenix, Pittsburgh, Portland, Richmond, Rochester, Saint Paul, Salt Lake City, San Diego, Santa Monica, Shenandoah, Springfield, Tacoma, Tyler, Wilmington, Winston-Salem, Ypsilanti
- Életkor
- 18 év to 130 év
- People
- 1018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - 2. fázisTaking peopleGolcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
- Where
- Albert Lea, Eau Claire, Jacksonville, La Crosse, Mankato, Rochester, Scottsdale
- Életkor
- 18 év and over
- People
- 41
- Run by
- Mayo Clinic
See details and how to joinNCT06834373 - 1. fázisNot yet taking people in Egyesült ÁllamokAxatilimab + CAR-T for High-Risk Lymphoma
- Where
- Atlanta
- Életkor
- 8 év and over
- People
- 29
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT07638982 - 2. fázisTaking peopleTesting Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Where
- Albuquerque, Atlanta, Baltimore, Baton Rouge, Battle Creek, Boiling Springs, Boise, Burlington, Charleston, Charlotte, Chicago, Cleveland, Clinton Township, Concord, Costa Mesa, Danville, Dearborn, Detroit, Durham, Easley, Fargo, Farmington Hills, Fayetteville, Fruitland, Gainesville, Grand Rapids, Greenville, Greer, Iowa City, Irvine, Jackson, Kalamazoo, Kansas City, Laguna Hills, Lebanon, Little Rock, Louisville, Madison, Maywood, Memphis, Meridian, Milwaukee, Muskegon, Nampa, Newberg, New Berlin, New York, Niles, Norton Shores, Novi, Oklahoma City, Orange, Oregon City, Overland Park, Philadelphia, Portland, Reed City, Richmond, Rochester, Rogers, Saint Johnsbury, Saint Joseph, San Francisco, Seattle, Seneca, Southfield, Springdale, Traverse City, Tucson, Twin Falls, Webster, West Bloomfield, Westwood, Wilkes-Barre, Winston-Salem, Wyandotte, Wyoming
- Életkor
- 18 év and over
- People
- 396
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT05633615 - 1. fázisTaking peopleA Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Where
- East Brunswick, Grand Rapids, Houston, Jacksonville, Los Angeles
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT07424833 - 2. fázisTaking peopleTafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 30
- Run by
- University of Washington
See details and how to joinNCT07731789 - 2. fázisNot yet taking people in Egyesült ÁllamokPrizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell Therapy
- Where
- Gilbert, La Jolla
- Életkor
- 18 év and over
- People
- 55
- Run by
- AbelZeta Inc.
See details and how to joinNCT07875413 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Austin, Charlotte, Chicago, Columbus, Duarte, Houston, Iowa City, Jacksonville, Milwaukee, Nashville, New Brunswick, New York, Overland Park, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, St Louis, Tampa, Waukee
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 1. fázisTaking peopleCD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Where
- Boston
- Életkor
- 18 év and over
- People
- 24
- Run by
- Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06026319 - No phaseTaking peopleA Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Where
- Bethesda, Charlotte, Cincinnati, Columbus, Fargo, Iowa City, Maumee, Reno, Rochester, Sioux Falls, St Louis, York
- Életkor
- 0 év and over
- People
- 550
- Run by
- Tempus AI
See details and how to joinNCT07154823 - 2. fázisTaking peopleLoncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT05672251 - 2. fázisTaking peopleEmapalumab Prevention of CAR-T Cell Associated Toxicities
- Where
- Boston
- Életkor
- 18 év and over
- People
- 28
- Run by
- Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06550141 - 1. fázisTaking peoplePhase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Where
- Ann Arbor, Aurora, Chicago, Detroit, Duarte, Houston, Los Angeles, New York, Pittsburgh, Scottsdale
- Életkor
- 18 év and over
- People
- 46
- Run by
- SciTech Development, Inc.
See details and how to joinNCT04234048 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Augusta, Baton Rouge, Bethesda, Birmingham, Boston, Buffalo, Chattanooga, Detroit, Fort Collins, Houston, Iowa City, Jacksonville, La Jolla, Las Vegas, Louisville, Miami, Nashville, Newnan, New York, Palo Alto, Phoenix, Richmond, Rochester, Santa Monica, Scottsdale, Seattle, Tampa, Tucson, Zion
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Boston, Charlotte, Hackensack, Houston, La Jolla, New York, Rochester, Seattle, Winston-Salem
- Életkor
- 18 év and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - 2. fázisTaking peopleRituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Where
- Tampa
- Életkor
- 18 év and over
- People
- 43
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06350318 - 2. fázisTaking peopleEpco, Zanu, Ritux for R/R FL or MZL
- Where
- Boston, Columbus, New York
- Életkor
- 18 év and over
- People
- 71
- Run by
- Reid Merryman, MD
See details and how to joinNCT06563596 - No phaseTaking peopleVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Where
- Portland
- Életkor
- 18 év and over
- People
- 45
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06784167 - 2. fázisTaking peopleMosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
- Where
- Duarte, Irvine
- Életkor
- 18 év and over
- People
- 41
- Run by
- City of Hope Medical Center
See details and how to joinNCT06453044 - 1. fázisTaking peoplehuCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
- Where
- Philadelphia
- Életkor
- 18 év and over
- People
- 6
- Run by
- University of Pennsylvania
See details and how to joinNCT07343934